Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

A combined index to classify prognostic comorbidity in candidates for radical prostatectomy.

Froehner M, Kellner AE, Koch R, Baretton GB, Hakenberg OW, Wirth MP.

BMC Urol. 2014 Mar 29;14:28. doi: 10.1186/1471-2490-14-28.

2.
3.

[The significance of comorbidity and age in radical prostatectomy].

Wirth M, Fröhner M.

Urologe A. 2004 Aug;43(8):935-41. German.

PMID:
15278203
4.

Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy.

Froehner M, Koch R, Litz R, Oehlschlaeger S, Noack B, Manseck A, Albrecht DM, Wirth MP.

Urology. 2003 Mar;61(3):596-600.

PMID:
12639654
5.

Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.

Froehner M, Koch R, Litz RJ, Oehlschlaeger S, Twelker L, Hakenberg OW, Wirth MP.

Urology. 2008 Dec;72(6):1252-7. doi: 10.1016/j.urology.2008.05.037. Epub 2008 Aug 23.

PMID:
18723211
6.

Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy.

Froehner M, Koch R, Litz RJ, Haase M, Klenk U, Oehlschlaeger S, Baretton GB, Wirth MP.

Scand J Urol Nephrol. 2005;39(6):449-54.

PMID:
16303719
7.

Which comorbidity classification best fits elderly candidates for radical prostatectomy?

Froehner M, Hentschel C, Koch R, Litz RJ, Hakenberg OW, Wirth MP.

Urol Oncol. 2013 May;31(4):461-7. doi: 10.1016/j.urolonc.2011.03.002. Epub 2011 Apr 16.

PMID:
21498089
8.

Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy.

Froehner M, Koch R, Litz RJ, Oehlschlaeger S, Hakenberg OW, Wirth MP.

Eur Urol. 2005 Feb;47(2):190-5; discussion 195.

PMID:
15661413
9.

Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.

Lee JY, Kang HW, Rha KH, Cho NH, Choi YD, Hong SJ, Cho KS.

J Cancer Res Clin Oncol. 2016 Apr;142(4):849-58. doi: 10.1007/s00432-015-2093-0. Epub 2015 Dec 12.

PMID:
26660495
10.

Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age.

Froehner M, Koch R, Litz RJ, Hakenberg OW, Oehlschlaeger S, Wirth MP.

Urology. 2006 Sep;68(3):583-6. Epub 2006 Sep 18.

PMID:
16979740
11.

Testing of a novel easy-to-use mortality index in a radical prostatectomy cohort.

Froehner M, Koch R, Hübler M, Litz R, Wirth MP.

Urology. 2014 Aug;84(2):307-12. doi: 10.1016/j.urology.2014.03.043. Epub 2014 Jun 21.

PMID:
24962844
12.

Impact of Charlson comorbidity index varies by age in patients with prostate cancer treated by radical prostatectomy: a competing risk regression analysis.

Lee JY, Lee DH, Cho NH, Rha KH, Choi YD, Hong SJ, Yang SC, Cho KS.

Ann Surg Oncol. 2014 Feb;21(2):677-83. doi: 10.1245/s10434-013-3326-6. Epub 2013 Oct 22.

PMID:
24145996
13.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

14.

Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.

Briganti A, Spahn M, Joniau S, Gontero P, Bianchi M, Kneitz B, Chun FK, Sun M, Graefen M, Abdollah F, Marchioro G, Frohenberg D, Giona S, Frea B, Karakiewicz PI, Montorsi F, Van Poppel H, Jeffrey Karnes R; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT).

Eur Urol. 2013 Apr;63(4):693-701. doi: 10.1016/j.eururo.2012.08.054. Epub 2012 Sep 5.

PMID:
22959192
15.

Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.

Cooperberg MR, Broering JM, Carroll PR.

J Natl Cancer Inst. 2009 Jun 16;101(12):878-87. doi: 10.1093/jnci/djp122. Epub 2009 Jun 9.

16.
17.

Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy.

Tollefson MK, Boorjian SA, Gettman MT, Rangel LJ, Bergstralh EJ, Karnes RJ.

Urol Oncol. 2013 Nov;31(8):1483-8. doi: 10.1016/j.urolonc.2012.03.014. Epub 2012 May 10.

PMID:
22578510
18.

Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.

Abdollah F, Sun M, Schmitges J, Thuret R, Bianchi M, Shariat SF, Briganti A, Jeldres C, Perrotte P, Montorsi F, Karakiewicz PI.

J Urol. 2012 Jul;188(1):73-83. doi: 10.1016/j.juro.2012.03.005. Epub 2012 May 12.

PMID:
22578732
19.

Which patients are at the highest risk of dying from competing causes ≤ 10 years after radical prostatectomy?

Froehner M, Koch R, Litz RJ, Hakenberg OW, Wirth MP.

BJU Int. 2012 Jul;110(2):206-10. doi: 10.1111/j.1464-410X.2011.10693.x. Epub 2011 Nov 1.

20.

Which conditions contributing to the Charlson score predict survival after radical prostatectomy?

Froehner M, Koch R, Litz R, Oehlschlaeger S, Wirth MP.

J Urol. 2004 Feb;171(2 Pt 1):697-9.

PMID:
14713789

Supplemental Content

Support Center